Picture of Duchembio Co logo

176750 Duchembio Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Duchembio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsARSAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,447-2,8324,0017,9946,480
Depreciation
Amortisation
Non-Cash Items-8875,1611,915-2,1211,393
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,570-1,390-3,234-4,409-4,804
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,0318,2368,4417,0299,939
Capital Expenditures-731-1,297-1,872-878
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items482465-1.856.6120
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities482-266-1,299-1,816-758
Financing Cash Flow Items-7.750
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-360-6,529-7,7663,507-4,422
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,1541,441-6258,7204,760